Eur J Pediatr Surg 2008; 18(4): 219-223
DOI: 10.1055/s-2008-1038502
Original Article

© Georg Thieme Verlag KG Stuttgart · New York

Congenital Diaphragmatic Hernia – The Neonatal Period (Part I)

G. M. Rocha1 , R. F. Bianchi2 , M. Severo3 , M. M. Rodrigues1 , M. J. Baptista4 , J. Correia-Pinto5 , H. A. Guimarães1
  • 1Department of Neonatology, Hospital de São João, Porto, Portugal
  • 2Department of Pediatrics, Hospital de São João, Porto, Portugal
  • 3Department of Epidemiology, Hospital de São João, Porto, Portugal
  • 4Department of Pediatric Cardiology, Hospital de São João, Porto, Portugal
  • 5Department of Pediatric Surgery, Hospital São João, Porto, Portugal
Further Information

Publication History

received December 15, 2007

accepted after revision February 19, 2008

Publication Date:
14 August 2008 (online)

Abstract

Aim: The aim of the study was to review our experience in the management of newborns with congenital diaphragmatic hernia (CDH). Methods: A retrospective study including all infants with CDH at the Hospital de São João, a center that does not provide ECMO support, for the period from 1997 to 2006. Since 2003, a new treatment protocol has been used. Results: There were 61 newborns (30 male/31 female) with a birth weight of 2800 g (880 – 3770), and a gestational age of 38 weeks (28 – 41); 46 (75 %) were inborn and 42 (69 %) had a prenatal diagnosis of CDH. There were 2 (3 %) chromosomal anomalies, 3 (5 %) with other congenital anomalies and 1 (2 %) with nonimmune hydrops fetalis. The diaphragmatic defect was left sided in 55 (90 %) cases. Corrective surgery was performed in 43 (70 %) patients. New therapies were used: HFOV 13 % (n = 8); inhaled nitric oxide 13 % (n = 8); and sildenafil 7 % (n = 4). We found that systemic arterial hypotension (p = 0.001), the severity of pulmonary hypertension (p = 0.001), prenatal diagnosis (p = 0.006), birth weight (p = 0.022), female gender (p = 0.029), inborn birth (p = 0.030), arterial pH < 7.35 at admission (p = 0.030), right-sided defect (p = 0.033) and pneumothorax (p = 0.033) to be predictive of mortality. The overall survival rate was 43 % (n = 26), and since 2003 this rate has improved to 61 % for term neonates without other congenital or chromosomal anomalies. Conclusions: Our survival rate for infants with CDH has improved over the last ten years, and this improvement is associated with the use of new therapies such as HFOV, inhaled nitric oxide and sildenafil.

References

  • 1 Azarow K, Messineo A, Pearl R, Filler R, Barker G, Bohn D. Congenital diaphragmatic hernia – a tale of two cities: the Toronto experience.  J Pediatr Surg. 1997;  32 395-400
  • 2 Bohn D. Diaphragmatic hernia. Pre and postnatal.  Pediatr Respir Rev. 2006;  7 (Suppl. 1) S249-S250
  • 3 Bohn D. Congenital diaphragmatic hernia.  Am J Respir Crit Care Med. 2002;  166 911-915
  • 4 Boloker J, Bateman D A, Wung J T, Stolar C J. Congenital diaphragmatic hernia in 120 infants treated consecutively with permissive hypercapnea/spontaneous respiration/elective repair.  J Pediatr Surg. 2002;  37 357-366
  • 5 Boucherat O, Benachi A, Chailley-Heu B, Franco-Montoya M L, Elie C, Martinovic J, Bourbon J R. Surfactant maturation is not delayed in human fetuses with diaphragmatic hernia.  http://www.plosmedicine.org 2007;  4 e237
  • 6 Cacciari A, Ruggeri G, Mordenti M, Ceccarelli P L, Baccarini E, Pigna A, Gentili A. High-frequency oscillatory ventilation versus conventional mechanical ventilation in congenital diaphragmatic hernia.  Eur J Pediatr Surg. 2001;  11 3-7
  • 7 Chen C, Jeruss S, Chapman J S, Terrin N, Tighiouart H, Glassman E, Wilson J M, Parsons S K. Long-term functional impact of congenital diaphragmatic hernia repair on children.  J Pediatr Surg. 2007;  42 657-665
  • 8 Colvin J, Bower C, Dickinson J E, Sokol J. Outcomes of congenital diaphragmatic hernia: a population-based study in Western Australia.  Pediatrics. 2005;  116 e356-e363
  • 9 Congenital Diaphragmatic Hernia Study Group . Defect size determines survival in infants with congenital diaphragmatic hernia.  Pediatrics. 2007;  120 e651-e657
  • 10 Congenital Diaphragmatic Hernia Study Group . Estimating disease severity of congenital diaphragmatic hernia in the first five minutes of life.  J Pediatr Surg. 2001;  36 141-145
  • 11 Chu S M, Hsieh W S, Lin J N, Yang P H, Fu R H, Kuo C Y. Treatment and outcome of congenital diaphragmatic hernia.  J Formos Med Ass. 2000;  99 844-847
  • 12 Downard C D, Wilson J M. Current therapy of infants with congenital diaphragmatic hernia.  Semin Neonatol. 2003;  8 215-221
  • 13 Downard C D, Jaksic T, Garza J J, Dzakovic A, Nemes L, Jennings R W, Wilson J M. Analysis of an improved survival rate for congenital diaphragmatic hernia.  J Pediatr Surg. 2003;  38 729-732
  • 14 Doyle N M, Lally K P. The CDH Study Group and advances in the clinical care of the patient with congenital diaphragmatic hernia.  Semin Perinatol. 2004;  28 174-184
  • 15 Frenckner B, Ehren H, Granholm T, Linden V, Palmer K. Improved results in patients who have congenital diaphragmatic hernia using preoperative stabilization, extracorporeal membrane oxygenation, and delayed surgery.  J Pediatr Surg. 1997;  32 1185-1189
  • 16 Geggel R L, Murphy J D, Langleben D, Crone R K, Vacanti J P, Reid L M. Congenital diaphragmatic hernia: arterial structural changes and persistent pulmonary hypertension after surgical repair.  J Pediatr. 1985;  107 457-464
  • 17 Javid P J, Jaksic T, Skarsgard E D, Lee S. Canadian Neonatal Network . Survival rate in congenital diaphragmatic hernia: the experience of the Canadian Neonatal Network.  J Pediatr Surg. 2004;  39 657-660
  • 18 Kim D H, Park J D, Kim H S, Shim S Y, Kim E K, Kim B I, Choi J H, Park G W. Survival rate changes in neonates with congenital diaphragmatic hernia and its contributing factors.  J Korean Med Sci. 2007;  22 687-692
  • 19 Lally K P. Congenital diaphragmatic hernia.  Curr Opin Pediatr. 2002;  14 486-490
  • 20 Langham M R, Kays D W, Beierle E A, Chen M K, Mullet T C, Rieger K, Wood C E, Talbert J L. Twenty years of progress in congenital diaphragmatic hernia at the University of Florida.  Am Surg. 2003;  69 45-52
  • 21 Logan J W, Rice H E, Goldberg R N, Cotton C M. Congenital diaphragmatic hernia: a systematic review and summary of best-evidence practice strategies.  J Perinatol. 2007;  27 535-549
  • 22 Mallik K, Rodgers B M, McGahren E D. Congenital diaphragmatic hernia: experience in a single institution from 1978 through 1994.  Ann Thorac Surg. 1995;  60 1331-1335
  • 23 Moya F R, Lally K P. Evidence-based management of infants with congenital diaphragmatic hernia.  Semin Perinatol. 2005;  29 112-117
  • 24 Noori S, Friedlich P, Wong P, Garingo A, Seri I. Cardiovascular effects of sildenafil in neonates and infants with congenital diaphragmatic hernia and pulmonary hypertension.  Neonatol. 2007;  91 92-100
  • 25 Okuyama H, Kubota A, Oue T, Kuroda S, Ikegami R, Kamiyama M, Kitayama Y, Yagi M. Inhaled nitric oxide with early surgery improves the outcome of antenatally diagnosed congenital diaphragmatic hernia.  J Pediatr Surg. 2002;  37 1188-1190
  • 26 Osiovich H C. Improving survival of neonates with isolated congenital diaphragmatic hernia.  Ind Pediatr. 2004;  41 1138-1142
  • 27 Rozmiarek A J, Qureshi F G, Cassidy L, Ford H R, Hackman D J. Factors influencing survival in newborns with congenital diaphragmatic hernia: the relative role of timing of surgery.  J Pediatr Surg. 2004;  39 821-824
  • 28 Salguero E, Gonzalez de Dios J, Garcia del Rio M, Sanchez Diaz F. Controversies in the therapeutical management of congenital diaphragmatic hernia: update by means of evidence-based medicine.  Cir Pediatr. 2005;  18 170-181
  • 29 The Neonatal Inhaled Nitric Oxide Study Group (NINOSG) . Inhaled nitric oxide and hypoxic respiratory failure in infants with congenital diaphragmatic hernia.  Pediatrics. 1997;  99 838-845
  • 30 Wilson J M, Lund D P, Lillehei C W, Vacanti J P. Congenital diaphragmatic hernia: a tale of two cities: the Boston experience.  J Pediatr Surg. 1997;  32 401-405

Dr. Gustavo Marcondes Rocha

Department of Neonatology
Hospital de São João

Alameda Professor Hernani Monteiro

4202-451 Porto

Portugal

Email: gusrocha@oninet.pt

    >